Innovex International, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $978.3M | $660.8M | $424.1M | $361.9M | $322.4M |
| Cost of revenue | $675.0M | $428.2M | $360.1M | $309.1M | $309.3M |
| Selling, general & administrative | $128.8M | $116.2M | $72.8M | $59.2M | $115.0M |
| Research and development | $6.7M | $3.7M | $3.0M | $2.5M | — |
| Operating income | $132.6M | $49.1M | $97.3M | $75.8M | -$125.3M |
| Interest expense | $2.6M | $2.4M | $5.5M | $4.0M | $787,000 |
| Pretax income | $128.5M | $142.8M | $94.4M | $72.9M | -$125.5M |
| Income tax expense | $45.2M | $2.5M | $20.4M | $9.7M | $2.9M |
| Net income | $83.3M | $140.3M | $73.9M | $63.3M | -$128.5M |
| Balance Sheet | |||||
| Cash and equivalents | — | — | $187.3M | $259.4M | $355.5M |
| Current assets | $728.0M | $641.4M | $288.3M | $750.0M | $745.1M |
| Total assets | $1.3B | $1.2B | $475.3M | $970.0M | $1.0B |
| Current liabilities | $148.2M | $162.7M | $78.6M | $87.6M | $93.7M |
| Total liabilities | $210.6M | $239.3M | $146.4M | $97.6M | $113.3M |
| Stockholders' equity | $1.1B | $958.2M | $328.9M | $251.3M | $180.6M |
| Cash Flow Statement | |||||
| Cash from operations | $190.9M | $93.4M | $75.9M | -$5.8M | $38.4M |
| Depreciation and amortization | $60.7M | $31.2M | $22.7M | $18.5M | $30.4M |
| Stock-based compensation | $13.8M | $13.2M | $2.0M | $907,000 | $14.9M |
| Capital expenditure | $14,000 | $1.6M | $32.6M | $18.9M | $10.0M |
| Free cash flow | $190.9M | $91.8M | $43.2M | -$24.7M | $28.4M |
| Dividends paid | $0 | $75.0M | $0 | $0 | — |
| Share repurchases | $9.3M | $0 | $0 | $20.8M | $24.2M |
| Impairments | $0 | $0 | $0 | $5.7M | $4.2M |
Shares outstanding 68.8M · Free float 5.7%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.